Baños Gutiérrez J L, Martín Portillo J A, Diego Ballestero R, Guerrero Zubillaga S, Barselo Ramos E, Sañudo Campos J A
Servicio de Urología, Hospital Universitario Valdecilla, Santander.
Actas Urol Esp. 2008 Feb;32(2):220-4. doi: 10.1016/s0210-4806(08)73816-6.
Nearly 50% of liver transplant recipients have some degree of renal failure; patients in haemodialysis treatment have a higher risk of suffering hepatic diseases related to viral infections or concomitant pathologies. Improvement in surgical and organ preservation techniques and immunosuppressive therapy has permitted multiorganic transplants in patients needing both liver and kidney organs.
To review our results in renal transplants in those patients with liver and kidney transplants.
Retrospective study of the 15 patients with liver and kidney transplants performed in our Hospital. We have reviewed patients main characteristics, liver and renal failure causes, renal graft and patient outcome and complications relate to renal transplant.
Between 1975 and December 2006 we performed 1483 kidney transplants and between 1991 and December 2006, 409 liver transplants. We performed multiorganic liver and kidney transplants to 15 patients (4 women and 11 men). The average for liver transplant recipients was 52.5+/-9.3 years (range 37-61) and for kidney transplant recipients was 51+/-12.5 years (35-66). Cold ischemia was 6.4+/-5.4 hours (6-8) in simultaneous liver-kidney transplant and 20.5+/-5.4 (8-27 hours) in non-simultaneous ones. Three patients had a renal transplant before the liver one (two functioning which had no changes after hepatic transplant but the other was lost due to IgA glomeruloneprhitis relapse and received a simultaneous kidney-liver transplant). Six patients received a simultaneous kidney-liver transplant and eight patients a renal transplant between 16 and 83 months (x=50.5+/-25.9 months) after the liver transplant. A renal graft was lost due to renal vein thrombosis and two due to IgA relapse; the others were functioning between 6 and 264 months of follow-up (x=92.5+/-66.7) with creatinine levels of 1.86+/-mg/100, (range 1-4.5). Four patients died due to hepatic failure between 8 months and 21 years after renal transplant and another died of oesophagus cancer 14 years after the kidney transplant, in all cases with functioning renal graft. There were no cases of kidney graft acute rejection in simultaneous transplants but there were five in non-simultaneous ones. Immunotherapy was based on steroids and tacrolimus.
Liver-kidney transplants are worthy options in patients with hepatic and renal end failure. Acute rejection seems to have fewer incidences in simultaneous liver-kidney transplantation.
近50%的肝移植受者存在一定程度的肾衰竭;接受血液透析治疗的患者患与病毒感染或并发疾病相关的肝病风险更高。手术和器官保存技术以及免疫抑制疗法的改进使得需要肝脏和肾脏器官的患者能够接受多器官移植。
回顾我们在肝肾联合移植患者中进行肾移植的结果。
对我院进行的15例肝肾联合移植患者进行回顾性研究。我们回顾了患者的主要特征、肝肾功能衰竭的原因、肾移植情况、患者结局以及与肾移植相关的并发症。
1975年至2006年12月期间,我们共进行了1483例肾移植,1991年至2006年12月期间,进行了409例肝移植。我们对15例患者(4名女性和11名男性)进行了肝肾联合移植。肝移植受者的平均年龄为52.5±9.3岁(范围37 - 61岁),肾移植受者的平均年龄为51±12.5岁(范围35 - 66岁)。肝肾联合移植的冷缺血时间为6.4±5.4小时(6 - 8小时),非同时移植的冷缺血时间为20.5±5.4小时(8 - 27小时)。3例患者在肝移植前进行了肾移植(其中2例移植肾功能良好,肝移植后无变化,但另一例因IgA肾小球肾炎复发而丢失,随后接受了肝肾联合移植)。6例患者接受了肝肾联合移植,8例患者在肝移植后16至83个月(平均50.5±25.9个月)进行了肾移植。1例移植肾因肾静脉血栓形成而丢失,2例因IgA复发而丢失;其余移植肾在随访6至264个月(平均92.5±66.7个月)期间功能良好,肌酐水平为1.86±mg/100(范围1 - 4.5)。4例患者在肾移植后8个月至21年因肝功能衰竭死亡,另1例在肾移植后14年死于食管癌,所有病例的移植肾功能均良好。同时移植的病例中未发生移植肾急性排斥反应,但非同时移植中有5例发生。免疫治疗基于类固醇和他克莫司。
肝肾联合移植对于终末期肝肾功能衰竭患者是值得选择的方案。肝肾联合移植中急性排斥反应的发生率似乎较低。